Back to Agenda
Conference Insights and Outcomes – Rapid Fire Session
Session Chair(s)
Holger G. Adelmann
Senior Vice President and Managing Director
DIA, Switzerland
Susan Forda, PhD
VP, GLobal Regulatory Affairs International
Eli Lilly & Company Ltd., United Kingdom
Ian Hudson
Senior Advisor, Integrated Development
Bill and Melinda Gates Foundation, United States
This must-attend ‘Rapid Fire’ session is an excellent opportunity to hear what you have missed in the sessions that you could not attend! All Theme Leaders will have 3 minutes on stage to share the essence from the presentations & discussions in their themes by delivering you summaries of novel insights and key takeaways from the DIA EuroMeeting. DIA is capturing emerging knowledge and insights in order to advance selected topics after the meeting
Speaker(s)
Theme 01 - Globalisation of Health Care Product Development
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
Theme 01 - Globalisation of Health Care Product Development
Gerhard Schlueter, DrSc, MSc
Bayer AG, Germany
Head of Strategic and Technical Operations, Regulatory Affairs
Theme 02 - Innovation of Health Care Development
Salah-Dine Chibout
Novartis Pharma AG, Switzerland
Global Head Discovery & Investigative Safety/Preclinical Safety Therapeutic Area
Theme 02 - Innovation of Health Care Development
Hans-Georg Eichler, MD, MSc
Austrian Association of Social Security Bodies, Austria
Consulting Physician
Theme 03 - Current Challenges in Clinical Research
Jens Heisterberg, MD
Novo Nordisk, Denmark
Vice President, Regulatory Intelligence
Theme 03 - Current Challenges in Clinical Research
Steffen Thirstrup, MD, PhD
European Medicines Agency, Netherlands
Chief Medical Officer
Theme 04 - eHealth/Big Data/Master- and Reference Data Management
Terje Peetso
European Commission, Belgium
Policy Officer, Unit H1
Theme 04 - eHealth/Big Data/Master- and Reference Data Management
Hans van Bruggen, MSc
Qdossier, a Celegence Company, Netherlands
CSO
Theme 05 - Pharmacovigilance
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert
Theme 05 - Pharmacovigilance
Phil Tregunno
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Deputy Director - Patient Safety Monitoring
Theme 06 - Regulatory Science
Zaide Frias, PharmD
European Medicines Agency, Netherlands
Head of Digital Business Transformation Task Force
Theme 06 - Regulatory Science
Trine B. Moulvad, MSc
Lundbeck, Denmark
Global RA, Medical Documentation and R&D QA
Theme 07 - Medical Devices and Combination Products
Gert Bos, PhD, MSc
Qserve Group B.V., Netherlands
Chief Scientific Oficer, Executive Director, Partner
Theme 07 - Medical Devices and Combination Products
John Wilkinson
MHRA, United Kingdom
Director of Devices
Theme 08 - HTA, Value and Access
Claes Buxfeldt, MSc
Astrazeneca, Sweden
Global Price and Reimbursement Director
Theme 08 - HTA, Value and Access
Ana Palma, PharmD
Sobi, Belgium
Senior Director Global Head Patient Access & Policy
Theme 09 - Information on Medicines, Medical Writing and Dossier Generation
Juan Garcia-Burgos, MD, PhD
European Medicines Agency, Netherlands
Head of Public and Stakeholders Engagement Department
Theme 10 - Special Populations
Geneviève Le Visage, PharmD, MSc
Novartis Pharma AG, Switzerland
Head EU RA Policy and Liaison
Have an account?